Zydus Lifesciences Ltd Quarterly Result
Zydus Lifesciences Ltd
NSE: ZYDUSLIFE
Net Profit - Last Quarter
Zydus Lifesciences Ltd Quarterly Results Key Highlights
- The revenue of Zydus Lifesciences Ltd for the Dec '25 is ₹ 6975 crore as compare to the Sep '25 revenue of ₹ 6232 crore.
- This represent the growth of 11.93% The ebitda of Zydus Lifesciences Ltd for the Dec '25 is ₹ 1842 crore as compare to the Sep '25 ebitda of ₹ 2090 crore.
- This represent the decline of -11.85% The net profit of Zydus Lifesciences Ltd for the Dec '25 is ₹ 965.1 crore as compare to the Sep '25 net profit of ₹ 1233 crore.
- This represent the decline of -21.75%.
Zydus Lifesciences Ltd Quarterly Results Analysis
Market Price of Zydus Lifesciences Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
| Date |  Price (₹) |
|---|---|
| 15 May 2026 | 1011.25 |
| 14 May 2026 | 991.3 |
| 13 May 2026 | 938.95 |
| 12 May 2026 | 930.75 |
| 11 May 2026 | 956.65 |
| 08 May 2026 | 938.9 |
| 07 May 2026 | 940.1 |
| 06 May 2026 | 939.1 |
| 05 May 2026 | 911.85 |
| 04 May 2026 | 901.65 |
Historical Revenue of Zydus Lifesciences Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.
Historical Revenue of Zydus Lifesciences Ltd
Historical EBITDA of Zydus Lifesciences Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Zydus Lifesciences Ltd
Historical Net Profit of Zydus Lifesciences Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Zydus Lifesciences Ltd
Zydus Lifesciences Ltd News Hub
Zydus Life gains as Q1 PAT climbs 31% YoY to Rs 1,420 cr
Revenue from operations jumped 20.77% year on year (YoY) to Rs 6,207.5 crore in the quareter ended 3
Read more
09 Aug 24
Zydus Lifesciences consolidated net profit rises 30.64% in the June 2024 quarter
Net profit of Zydus Lifesciences rose 30.64% to Rs 1419.90 crore in the quarter ended June 2024 as a
Read more
09 Aug 24
Zydus receives USFDA approval for Valbenazine Capsules
Zydus Lifesciences has received final approval from the United States Food and Drug Administration (
Read more
09 Aug 24
Zydus Lifesciences Ltd soars 1.83%, rises for third straight session
Zydus Lifesciences Ltd is up for a third straight session in a row. The stock is quoting at Rs 1296.
Read more
08 Aug 24
Document
Annual Reports
Annual Report 2024
Credit Ratings
Credit Report 2024
Concalls
Popular Search
About Zydus Lifesciences Ltd
- Zydus Lifesciences Limited, initially known as Cadila Healthcare Limited was incorporated in May, 1995, which changed to Zydus Lifesciences Limited on February 24, 2022.
- The Company is one of the leading innovation driven pharmaceutical companies in India with presence across the pharmaceutical value chain including innovating (research & development), manufacturing, marketing and selling of finished dosage human formulations (generics, branded generics and specialty formulations, including biosimilars and vaccines), Active Pharmaceutical Ingredients (APIs), animal healthcare products and consumer wellness products.
- The Company operate manufacturing facilities at Ahmedabad, Ankleshwar and Vadodara in Gujarat, Ponda in Goa, Raigad in Maharashtra and Solan in Himachal Pradesh. The Company's operation includes pharmaceuticals, which includes human formulations, veterinary formulations and bulk durgs, diagnostics, herbal products, skin care products and OTC products.
FAQs for Quarterly Results of Zydus Lifesciences Ltd
What key financial metrics are included in Zydus Lifesciences Ltd's quarterly results?
When does Zydus Lifesciences Ltd announce its quarterly results?
How does Zydus Lifesciences Ltd's quarterly performance impact its stock price?
What is the impact of Zydus Lifesciences Ltd's quarterly results on dividends?
Are there any special announcements usually made during Zydus Lifesciences Ltd's quarterly results?
